HOME | SITEMAP | CONTACT US









 
   
About the NCCR
Committee Members
Services & Guidelines
Approved Research
Clinical Investigators
Useful Links
NCCR Bulletin
MOH News
Contact Us







  Members of NCCR

The current composition of the NCCR was established to ensure that it becomes visionary and pro-active in driving the development of clinical research in the country.

The committee is made up of member representatives and experts from the Ministry of Health (MOH), various national Universities, the Malaysian Pharmaceutical Society (MPS), the Pharmaceutical Association of Malaysia (PhAMA), the Malaysian Organisation of Pharmaceutical Industries (MOPI), as well as other Non-Governmental Organisations. The composition of the member representatives reflects the on-going “smart-partnerships” amongst the various stake-holders with interests in quality clinical research in Malaysia.

The NCCR committee members for the 1 June 2016 – 31 May 2019 term are: 

Bil Nama Alamat Jawatan
1 Datuk Dr. Noor Hisham Bin Abdullah
Ketua Pengarah Kesihatan Malaysia
Aras 12, Blok E7, Kompleks E, Pusat Pentadbiran Kerajaan Persekutuan, 62590 Putrajaya. Pengerusi
2 Datuk Dr. Shahnaz Murad,
Timbalan Ketua Pengarah Kesihatan Malaysia (Penyelidikan dan Sokongan Teknikal),
Aras 12, Blok E7, Kompleks E, Pusat Pentadbiran Kerajaan Persekutuan, 62590 Putrajaya. Ahli
3 Dato’ Dr Azman Hj Abu Bakar
Pengarah,  
Bahagian Perkembangan Perubatan, Kementerian Kesihatan Malaysia, Aras 3-7, Blok E1 Kompleks E, Pusat Pentadbiran Kerajaan Persekutuan, 62590 Wilayah Persekutuan Putrajaya. Ahli
4 Profesor Dato’ Paduka Dr. Khalid Hj. Yusoff Naib Canselor dan Presiden,   UCSI University, No. 1, Jalan Menara Gading, UCSI Heights, Cheras, 56000 Kuala Lumpur. Ahli
5 Dr Salina Abdul Aziz
Pengerusi,  
Jawatankuasa Etika & Penyelidikan Perubatan, Kementerian Kesihatan Malaysia, d/a Institut Pengurusan Kesihatan, Jalan Rumah Sakit, Bangsar, 59000 Kuala Lumpur. Ahli
6 Dr. Goh Pik Pin
Pengarah,  
Rangkaian Pusat Penyelidikan Klinikal, Level 3, Dermatology Block, Hospital Kuala Lumpur, Jalan Pahang, 50586 Kuala Lumpur. Ahli
7 Profesor Datin Dr. Zahurin Mohamed
Ketua Jabatan Farmakologi,
Pusat Perubatan Univerisiti Malaya, 50603 Kuala Lumpur. Ahli
8 Prof. Datuk Looi Lai Meng Jabatan Patologi, Fakulti Perubatan Universiti Malaya, 50603 Kuala Lumpur. Ahli
9 Dr Ramli Zainal
Pengarah,  
Agensi Regulatori Farmasi Negara, Lot 36, Jalan Universiti, 46200 Petaling Jaya. Ahli
10 Dr. Goh Cheng Soon   Bahagian Perubatan Tradisional & Komplementari, Kementerian Kesihatan Malaysia, Aras 1-3, Blok A, Jalan Cenderasari, 50590 Kuala Lumpur. Ahli
11 Dato’ Dr Fadzilah Kamaludin
Pengarah,  
Institut Penyelidikan Perubatan, Jalan Pahang, 50588 Kuala Lumpur. Ahli
12 Dr. S. Asmaliza Ismail   Ketua Urusetia NIH, Jalan Rumah Sakit, Bangsar, 59000 Kuala Lumpur. Ahli
13 Profesor Dr. Yeoh Peng Nam
Wakil Malaysia Pharmaceutical Society (MPS)
UCSI University No. 1, Jalan Menara Gading, UCSI Heights (Taman Connaught), 56000 Cheras, Kuala Lumpur Ahli
14 Dr. Akhmal Yusoff Ketua
Pengarah Eksekutif  
Clinical Reasearch Malaysia, Suite E-10-20, Amcorp Business Suites, Menara Melawangi, Amcorp Trade Centre, No 18, Jalan Persiaran Barat 46050 Petaling Jaya, Selangor Ahli
15 En. Zamane Abdul Rahman
Ketua Eksekutif,  
Pihak Berkuasa Peranti Perubatan, Level 5, Menara Prisma, No. 26, Jalan Persiaran Perdana Presint 3, 62675 Putrajaya. Ahli
16 Dr. Noraida Mohamad Zainoor
Timbalan Pengarah,  
Agensi Regulatori Farmasi Negara, Lot 36, Jalan Universiti, 46200 Petaling Jaya. Setiausaha
17 Professor Datuk A. Rahman A. Jamal
Pengarah  
Institut Perubatan Molekul, Universiti Kebangsaan Malaysia, Jalan Yaakob Latiff, Bandar Tun Razak, Cheras, 46000 Kuala Lumpur. Ahli
18 Dr. Sarojini Sivanandam
Wakil Contract Research Organization (CRO) Tempatan  
Klinsel Sdn Bhd Suite 16.03, 16th Floor, IGB Plaza (known as Plaza Permata), No. 6, Jalan Kampar off Jalan Tun Razak, 50400 Kuala Lumpur Ahli
19 Dr. Soraya Dato’ Seri Azmi
Wakil Contract Research Organization (CRO) Tempatan  
Azmi Burhani Consulting, Metropolitan Square, W103A, Jalan PJU 8/1, Damansara Perdana, 47820 Petaling Jaya, Selangor Ahli Silih Ganti
20 En. Goh Tse Seng
Wakil Contract Research Organization (CRO) Antarabangsa  
Quintiles Suite D-08-02 Plaza Mont' Kiara No.2 Jalan Kiara Mont' Kiara Malaysia Ahli
21 Puan Christine Siew Pui Yee,
Wakil Contract Research Organization (CRO) Antarabangsa  
Paraxel International (Malaysia) Sdn. Bhd. Unit 1104, Level 11 Uptown 2 No. 2, Jalan SS21/37 Damansara Uptown 47400 Petaling Jaya Selangor Ahli Silih Ganti
22 Pn Sabrina Haron
Wakil Malaysian Organisation of Pharmaceutical Industries (MOPI)  
CCM Duopahrma Biotech Berhad, Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya, 41200 Klang Ahli
23 Pn Vanessa Daniel
Wakil Malaysian Organisation of Pharmaceutical Industries (MOPI)  
Pharmaniaga Manufacturing Berhad 11A, Jalan P/1, Kawasan Perusahaan Bangi, 43650 Bandar Baru Bangi, Selangor. Ahli Silih Ganti
24 Dr Ashwaria Gupta
Chief Scientific Officer (CSO) Wakil Phama
Novartis Corporation (Malaysia) Sdn. Bhd. Jalan Kemajuan, Seksyen 12, 46200 Petaling Jaya, Selangor, Malaysia Ahli
25 Dr Rubentiran Ramar  
Wakil Phama
Medical Advisor,  AbbVie Sdn Bhd 24, Jalan Pemaju U1/15, Hicom-glenmarie Industrial Park, 40150 Shah Alam, Selangor, Malaysia Ahli Silih Ganti

 

Various Sub-committees are formed to facilitate the work and operations of the NCCR. These include:

•  Sub-committee on “Site Visit” for Clinical Research Infrastructure
This committee was established to identify the strengths and weaknesses of the present research centres infrastructure, and to take necessary actions in improving them so that clinical research can be carried out in Malaysia
•  Sub-committee for “Guidelines for Application to Conduct Drug-Related Clinical Trials in Malaysia”
Guidance for researchers and the pharmaceutical industries who are interested in conducting clinical research in Malaysia
•  Sub-committee for “Good Laboratory Practice” (GLP)
This committee was established to develop the Good Laboratory Practice (GLP) Guidelines and organise courses related to it
•  Sub-committee for Bio-Equivalence Studies (BE)
The “ASEAN Guidelines for the Conduct of Bioavailability and Bioequivalence Studies” which was prepared by Malaysia based on the "Malaysian Guidelines for the Conduct of Bioavailability and Bioequivalence Studies" was adopted by ASEAN with minor changes during the 8th ACCSQ PPWG Meeting in Bangkok, July 2004
•  Sub-Committee for Clinical Trial Import Licence
Guidance for researchers and the pharmaceutical industries who wish to import investigational products which are not registered in Malaysia for clinical research.

 

 



 Print Friendly [ Total Hits: 437117 | Page Hits: 29582 ]

 
 

This website is managed and sponsored by the Clinical Research Centre, Ministry of Health Malaysia
Copyright © 2005 - 2018 National Committee for Clinical Research (NCCR). All Rights Reserved.  
Powered by Cornerstone Content Management System